Lam Research Corporation (LRCX)
$210.69
-6.41 (-3.04%)Delayed quote.
Price history
Daily close- Start
- $143.24
- Latest close
- $210.69
- Period change
- +47.09%
- Period low
- $139.59
- Period high
- $433.33
Key metrics
- Market cap
- $255.36B
- Volume
- 1.82M
- Average volume
- 10.36M
- 52-week range
- $135.50 – $438.50
- Beta
- 2.01
- Last dividend
- $1.11
- EPS (TTM)
- $6.75
- P/E ratio
- 31.21
- Revenue (TTM)
- $26.13B
- Net income (TTM)
- $8.45B
- Total assets
- $26.35B
- Total debt
- $3.74B
- Cash and equivalents
- $7.44B
Key financials (trailing twelve months).
Company profile
Lam Research Corporation is a prominent supplier of equipment vital for semiconductor processing, encompassing its design, production, sales, repair, and ongoing maintenance. These sophisticated systems are fundamental for the creation of integrated circuits. The company's extensive product catalog features a variety of deposition technologies. For tungsten metallization, they provide ALTUS systems that deposit conformal films. SABRE products excel in electrochemical deposition, crucial for copper interconnect transitions and enabling copper damascene manufacturing. SOLA utilizes ultraviolet thermal processing for film treatments, while VECTOR delivers plasma-enhanced chemical vapor deposition (CVD) and atomic layer deposition (ALD) solutions. Furthermore, SPEED addresses gapfill applications with its high-density plasma CVD products, and Striker is engineered for single-wafer atomic layer deposition of dielectric films. Beyond deposition, Lam Research offers a comprehensive suite of etching tools. Flex is designed for dielectric etch applications, Kiyo handles conductor etch processes, Syndion specializes in through-silicon via etching, and Versys metal products are used for metal etch processes. The company's offerings also extend to specialized solutions like Coronus, which enhances die yield through bevel cleaning. For various wafer cleaning requirements, Lam Research supplies multiple product lines, including Da Vinci, DV-Prime, EOS, and SP series. Additionally, Metryx mass metrology systems provide precise, in-line mass measurement capabilities for semiconductor wafer manufacturing. Lam Research serves the global semiconductor industry, distributing its technologies and services across the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and other international markets. Established in 1980, the company maintains its corporate headquarters in Fremont, California.
- Sector
- Technology
- Industry
- Semiconductors
- Exchange
- NASDAQ
- CEO
- Timothy Archer
- Employees
- 24,300
- Headquarters
- Fremont, CA, US
- IPO date
- 1984-05-04
- Website
- https://www.lamresearch.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2026Jun 28, 2026 | FY2025Jun 29, 2025 | FY2024Jun 30, 2024 |
|---|---|---|---|
| Revenue | $23.23B | $18.44B | $14.91B |
| Gross profit | $11.73B | $8.98B | $7.05B |
| Operating income | $8.20B | $5.90B | $4.26B |
| EBITDA | $8.70B | $6.34B | $4.91B |
| Net income | $7.27B | $5.36B | $3.83B |
| Diluted EPS | $5.76 | $4.15 | $2.90 |
| Metric | FY2026Jun 28, 2026 | FY2025Jun 29, 2025 | FY2024Jun 30, 2024 |
|---|---|---|---|
| Cash and equivalents | $5.58B | $6.39B | $5.85B |
| Total assets | $23.53B | $21.35B | $18.74B |
| Total liabilities | $11.06B | $11.48B | $10.21B |
| Total debt | $4.12B | $4.76B | $4.98B |
| Shareholders’ equity | $12.47B | $9.86B | $8.54B |
| Metric | FY2026Jun 28, 2026 | FY2025Jun 29, 2025 | FY2024Jun 30, 2024 |
|---|---|---|---|
| Operating cash flow | $5.86B | $6.17B | $4.65B |
| Capital expenditure | -$966.40M | -$759.19M | -$396.67M |
| Free cash flow | $4.89B | $5.41B | $4.26B |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q1 2027Sep 27, 2026 | Q4 2026Jun 28, 2026 | Q3 2026Mar 29, 2026 | Q2 2026Dec 28, 2025 | Q1 2026Sep 28, 2025 | Q4 2025Jun 29, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $8.22B | $6.72B | $5.84B | $5.34B | $5.32B | $5.17B |
| Gross profit | $4.30B | $3.48B | $2.91B | $2.65B | $2.68B | $2.59B |
| Operating income | $3.28B | $2.51B | $2.05B | $1.81B | $1.83B | $1.74B |
| EBITDA | $3.43B | $2.59B | $2.17B | $1.98B | $1.96B | $1.88B |
| Net income | $2.75B | $2.28B | $1.83B | $1.59B | $1.57B | $1.72B |
| Diluted EPS | $2.19 | $1.81 | $1.45 | $1.26 | $1.24 | $1.35 |
| Metric | Q1 2027Sep 27, 2026 | Q4 2026Jun 28, 2026 | Q3 2026Mar 29, 2026 | Q2 2026Dec 28, 2025 | Q1 2026Sep 28, 2025 | Q4 2025Jun 29, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $7.44B | $5.58B | $4.75B | $6.18B | $6.69B | $6.39B |
| Total assets | $26.35B | $23.53B | $20.79B | $21.39B | $21.90B | $21.35B |
| Total liabilities | $12.44B | $11.06B | $10.21B | $11.25B | $11.71B | $11.48B |
| Total debt | $3.74B | $4.12B | $3.73B | $4.48B | $4.48B | $4.48B |
| Shareholders’ equity | $13.91B | $12.47B | $10.58B | $10.15B | $10.19B | $9.86B |
| Metric | Q1 2027Sep 27, 2026 | Q4 2026Jun 28, 2026 | Q3 2026Mar 29, 2026 | Q2 2026Dec 28, 2025 | Q1 2026Sep 28, 2025 | Q4 2025Jun 29, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $3.50B | $1.46B | $1.14B | $1.48B | $1.78B | $2.55B |
| Capital expenditure | -$257.70M | -$188.80M | -$331.60M | -$260.88M | -$185.12M | -$172.19M |
| Free cash flow | $3.24B | $1.27B | $809.82M | $1.22B | $1.59B | $2.38B |